Concepedia

Author

Jingjing Jiang

Revolution Medicines (United States)ORCID

Also Known As

J Jiang, J.K. Jiang, Jingjing Jiang

105

Publications

369

Citations

5

H-Index

0

Concepts

All Affiliations

Revolution Medicines (United States)Harvard University
JJ

About

Jingjing Jiang is an author at Revolution Medicines (United States).

Jingjing Jiang

×

4

Publications

357

Citations

4

H-Index

YearCitations

Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers

Jingjing Jiang, Lingyan Jiang, Benjamin J. Maldonato,

Cancer Discovery

2024

231

Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway

Xiaying Zhao, Jing Fu, An Xu,

Cell Death and Disease

2015

59

Mechanisms of Response and Tolerance to Active RAS Inhibition in <i>KRAS</i> -Mutant Non–Small Cell Lung Cancer

Haniel A. Araújo, Ximo Pechuan-Jorge, Teng Zhou,

Cancer Discovery

2024

50

A neomorphic protein interface catalyzes covalent inhibition of RAS <sup>G12D</sup> aspartic acid in tumors

Caroline E. Weller, G. Leslie Burnett, Lingyan Jiang,

Science

2025

17

Page 1